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Purpose: Osteoarthritis (OA) is the most common joint disease with a
great impact on the quality of life. Obesity and the related metabolic
disease are main risk factors, in which low-grade systemic inflamma-
tion is an important regulator. In this regard, the infrapatellar fat pad
(IPFP) also came forward as a local OA joint tissue, contributing to and
influenced by inflammatory responses in the OA knee.
Our study aims to investigate the association between obesity and local
inflammatory, fibrotic responses in the IPFP of obese end-stage knee OA
patients.
Methods: After ethical approval by the Central Denmark Region Com-
mittees on Health Research Ethics, human IPFPs were obtained as waste
material during total knee replacement in 48 patients with increased
body mass index (BMI) (mean 35.44kg/m2). The fat pads were frozen at
-80C maximum 1 hour after being removed. We performed gene
expression analyses for the following primers: PLOD2 (involved in the
regulation of hydroxyallysine collagen crosslinks), aSMA (correspond-
ing with the myofibroblast phenotype), COL1 (encoding for alfa-1 type
collagen), and IL6, TNFa, Il1b asmarkers of inflammation. Blood samples
(non-fasting) were collected to assess glucose, lipid status (total cho-
lesterol, HDL cholesterol, LDL cholesterol, and triglyceride). In addition,
serum leptin concentration was measured as a biomarker of adiposity.
Total body composition (fat mass, lean mass, and bone mass) was
measured using dual-energy X-ray absorptiometry.
Results: Univariate analysis of BMI and gene expression in IPFP explants
resulted in a positive correlation between BMI and PLOD2 expression
with 13.15% of the variance explained by this variable (r2¼0.1315). No
correlationwas found for BMI and other determinants of fibrosis such as
aSMA (a-smooth muscle actin) or COL1 (type I collagen a1 chain gene),
nor inflammatory markers such as TNFa, IL1ß or IL6. To explore the
correlation between BMI and PLOD2, metabolic factors associated with
BMI were also analyzed for correlation with PLOD2. In the univariate
analysis, significant correlations with PLOD2 expression were found for
lean and fat mass (r2¼0,1988), serum cholesterol (r2 ¼0,1669), serum
triglycerides (r2 ¼0.1861), and serum leptin (r2 ¼0.1040). A collinearity
plot was performed to investigate the correlation between all different
independent variables and PLOD2 before performing a multivariate
analysis. We withheld age, sex, glucose, fat mass, total cholesterol as
independent variables. The multivariate analysis with PLOD2 indicated
a strong correlation between fat mass and PLOD2 with a P-value of
0.0025. No other significant correlations were withheld within this
multivariate analysis.
Conclusions: Taken together, our study is the first to demonstrate the
positive association between fat-mass and PLOD2 expression in the IPFP
of end stage knee OA patients. This may indicate that the fibrotic
process in the IPFP in obese end-stage knee OA patients is influenced by
systemic adipose tissue , next to local inflammatory processes in the
knee joint, that may alter this proces.Further research is necessary to
confirm these findings and its role in the knee OA disease process.
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Purpose: The burden of osteoarthritis (OA) is often greater among
disadvantaged people and communities, prompting calls for more
attention to equity-focussed research and policy. A specific concern is
whether healthcare interventions may inadvertently widen health
inequalities. OA management programmes (OAMP) have emerged in
the past decade in a major international effort to improve provision of
core non-surgical care for people with OA. Recent studies have focussed
on equity of access. We address a complementary issue: having gained
access, do people from socially disadvantaged groups have poorer
outcomes than their advantaged counterparts, and if so, what might
determine this?
Methods: The study population was consecutive adults with knee OA
attending the 8-week GLA:D® supervised exercise and education pro-
gramme in Denmark between Oct 2014-Feb 2018. We defined a‘multiple social disadvantage’ group based on primary/secondary
school education and being either born outside Denmark or not having
Danish citizenship. Their outcomes were compared with those of native
Danish citizens with higher education. Outcomes of interest were pain
intensity (0-100 VAS), KOOS Quality of Life subscale (QOL 0-100), EQ-
5D-5L health utility (-0.624-1.0) at 3 and 12 months. Missing data were
imputed using multiple imputation with chained equations. We used
Coarsened Exact Matching (CEM) to restrict group comparisons to areas
of common support, i.e. sufficient overlap on key prognostic factors
(age, sex, body mass index, baseline value of the outcome measure of
interest). We then used Entropy Balancing to sequentially control for
differences between disadvantaged and advantaged groups in: (1)
baseline value of the outcomes of interest (2) type of treatment centre,
enrollment year (3) age, sex (4) BMI, previous knee injury, previous
knee surgery (5) no. of selected comorbidities, no. of other non-knee
pain sites (6) self-efficacy score, self-reported presence of depression
(7) previous/current tailored exercise advice, weight loss counselling,
analgesia/natural remedies (8) attendance at GLA:D® education and
exercise sessions. Mean differences in outcomes between dis-
advantaged and advantaged groups were then estimated by weighted
linear regression without balancing and then with entropy balancing
weights from steps 1-8.
Results: Of 18,448 eligible participants, 250 (1.4%) were classed as
disadvantaged. Compared with advantaged participants, they were
younger, less likely to have attended GLA:D® in a private physiotherapy
clinic, reported more comorbidity, pain sites, depression, lower self-
efficacy, and lower attendance on GLA:D® sessions. Both groups
showed overall improvements over baseline in mean pain VAS, KOOS
QOL and EQ5D scores at 3 months, typically maintained at 12 months.
Before covariate balancing, disadvantaged participants had sub-
stantially worse scores than advantaged participants on each measure
at both follow-up points (e.g. crude between-group mean differences
(95%CI) in pain VAS at 12 months: 8.6 (4.5, 12.6) respectively: Table 1).
Balancing for differences on baseline score, comorbidity, self-efficacy,
and depression had the greatest effect on reducing differences in
outcomes.
Conclusions: Both disadvantaged and advantaged adults with knee OA
reported improvements in key outcomes up to 12 months after OAMP
attendance. However, compared with more advantaged adults, dis-
advantaged adults typically began the OAMPwithmore severe pain and
poorer quality of life. This gap in outcomes was not reduced following
OAMP attendance: for generic health-related quality of life in particular
the gap widened slightly. Low self-efficacy, depression and other
comorbidities may be potential determinants. Our analysis is of
observed outcomes in a relatively small group with multiple dis-
advantage attending one OAMP. We encourage further work in other
settings and groups. If confirmed, our findings suggest that while
improving access to OAMPs for socially disadvantaged peoplewith OA is
important, additional actions may be needed to reduce outcome
inequalities.
